These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 17188756

  • 1. Neurodegeneration and -protection in autoimmune CNS inflammation.
    Diem R, Sättler MB, Bähr M.
    J Neuroimmunol; 2007 Mar; 184(1-2):27-36. PubMed ID: 17188756
    [Abstract] [Full Text] [Related]

  • 2. Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.
    Aktas O, Waiczies S, Zipp F.
    J Neuroimmunol; 2007 Mar; 184(1-2):17-26. PubMed ID: 17222462
    [Abstract] [Full Text] [Related]

  • 3. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.
    Hauser SL, Oksenberg JR.
    Neuron; 2006 Oct 05; 52(1):61-76. PubMed ID: 17015227
    [Abstract] [Full Text] [Related]

  • 4. Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.
    Ellwardt E, Zipp F.
    Exp Neurol; 2014 Dec 05; 262 Pt A():8-17. PubMed ID: 24530639
    [Abstract] [Full Text] [Related]

  • 5. HIV-Tat-mediated Bcl-XL delivery protects retinal ganglion cells during experimental autoimmune optic neuritis.
    Diem R, Taheri N, Dietz GP, Kuhnert A, Maier K, Sättler MB, Gadjanski I, Merkler D, Bähr M.
    Neurobiol Dis; 2005 Nov 05; 20(2):218-26. PubMed ID: 16242630
    [Abstract] [Full Text] [Related]

  • 6. Future neuroprotective strategies.
    Sättler MB, Bähr M.
    Exp Neurol; 2010 Sep 05; 225(1):40-7. PubMed ID: 19716365
    [Abstract] [Full Text] [Related]

  • 7. The molecular basis of neurodegeneration in multiple sclerosis.
    Lassmann H, van Horssen J.
    FEBS Lett; 2011 Dec 01; 585(23):3715-23. PubMed ID: 21854776
    [Abstract] [Full Text] [Related]

  • 8. Novel therapeutic targets for axonal degeneration in multiple sclerosis.
    Petratos S, Azari MF, Ozturk E, Papadopoulos R, Bernard CC.
    J Neuropathol Exp Neurol; 2010 Apr 01; 69(4):323-34. PubMed ID: 20448478
    [Abstract] [Full Text] [Related]

  • 9. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Reichardt HM, Gold R, Lühder F.
    Expert Rev Neurother; 2006 Nov 01; 6(11):1657-70. PubMed ID: 17144780
    [Abstract] [Full Text] [Related]

  • 10. Genetic dissection of neurodegeneration and CNS inflammation.
    Olsson T, Piehl F, Swanberg M, Lidman O.
    J Neurol Sci; 2005 Jun 15; 233(1-2):99-108. PubMed ID: 15894332
    [Abstract] [Full Text] [Related]

  • 11. Multiple sclerosis: a battle between destruction and repair.
    McQualter JL, Bernard CC.
    J Neurochem; 2007 Jan 15; 100(2):295-306. PubMed ID: 17101032
    [Abstract] [Full Text] [Related]

  • 12. New insights into adaptive immunity in chronic neuroinflammation.
    Siffrin V, Brandt AU, Herz J, Zipp F.
    Adv Immunol; 2007 Jan 15; 96():1-40. PubMed ID: 17981203
    [Abstract] [Full Text] [Related]

  • 13. The relation between MRI measures of inflammation and neurodegeneration in multiple sclerosis.
    Inglese M, Benedetti B, Filippi M.
    J Neurol Sci; 2005 Jun 15; 233(1-2):15-9. PubMed ID: 15949493
    [Abstract] [Full Text] [Related]

  • 14. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J, Paul F, Aktas O, Müller-Wielsch K, Dörr J, Dörr S, Bharathi BS, Glumm R, Schmitz C, Steinbusch H, Raine CS, Tsokos M, Nitsch R, Zipp F.
    Ann Neurol; 2009 Sep 15; 66(3):310-22. PubMed ID: 19798635
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Advancement of therapies for neuroprotection in multiple sclerosis.
    Lo A.
    Expert Rev Neurother; 2008 Sep 15; 8(9):1355-66. PubMed ID: 18759548
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Death ligands and autoimmune demyelination.
    Aktas O, Prozorovski T, Zipp F.
    Neuroscientist; 2006 Aug 15; 12(4):305-16. PubMed ID: 16840707
    [Abstract] [Full Text] [Related]

  • 19. Bladder dysfunction in multiple sclerosis.
    McCombe PA, Gordon TP, Jackson MW.
    Expert Rev Neurother; 2009 Mar 15; 9(3):331-40. PubMed ID: 19271942
    [Abstract] [Full Text] [Related]

  • 20. The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience.
    Karussis D, Kassis I.
    Clin Neurol Neurosurg; 2008 Nov 15; 110(9):889-96. PubMed ID: 18375051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.